MedAvail Holdings, Inc. (MDVL)

MedAvail Holdings, Inc. (MDVL) Healthcare & Pipeline Overview

MedAvail Holdings, Inc. is a technology-enabled retail pharmacy company specializing in self-service dispensing solutions. Through its MedCenter kiosks and SpotRx platform, it provides on-site prescription access with live pharmacist supervision, serving medical clinics, retail stores, and employer sites in the U.S. and Canada.

What Is the Investment Thesis for MDVL?

MedAvail Holdings, Inc. presents an investment thesis centered on its innovative approach to prescription dispensing through technology-enabled self-service solutions. The company's value proposition is rooted in addressing the growing demand for convenient and accessible healthcare services, particularly in pharmacy. Key value drivers include the proprietary MedCenter kiosks, which enable on-site prescription dispensing with real-time pharmacist supervision, and the SpotRx retail pharmacy platform, expanding its direct patient reach. As of December 31, 2021, the company had deployed 81 MedCenter kiosks, forming a foundational network for future expansion. Despite a current market capitalization of $2.91M and significant negative profitability, evidenced by a -110.5% profit margin and a 6.0% gross margin, the thesis hinges on the potential for scaling its technology and services. Growth catalysts include the continued expansion of its MedCenter kiosk footprint into new medical clinics, retail locations, and employer sites across the U.S. and Canada. Further development and adoption of the SpotRx platform could also drive revenue growth. The company's model aims to reduce operational costs associated with traditional pharmacies while enhancing patient convenience. However, the current financial metrics indicate a company in an early or challenging growth phase, requiring substantial capital investment and successful market penetration to achieve profitability.

Based on FMP financials and quantitative analysis

MDVL Key Highlights

• Market capitalization of $2.91M, reflecting its current valuation.
• Reported a profit margin of -110.5%, indicating significant operational losses.
• Achieved a gross margin of 6.0%, suggesting high direct costs relative to revenue.
• Operates with a workforce of 279 employees across its segments.
• Deployed 81 MedCenter kiosks as of December 31, 2021, establishing its technology footprint.

Who Are MDVL's Competitors?

MDVL is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are MDVL's Key Strengths?

• Proprietary MedCenter kiosk technology and SpotRx retail pharmacy platform.
• Dual business model combining technology solutions with direct retail pharmacy services.
• Enhanced patient convenience through on-site, self-service prescription access.
• Integration of real-time audio-visual pharmacist supervision ensuring safety and compliance.

What Are MDVL's Weaknesses?

• Significant negative profit margin of -110.5% indicating substantial losses.
• Low gross margin of 6.0% impacting overall profitability.
• Small market capitalization of $2.91M, suggesting limited market presence or early stage.
• Limited network of 81 MedCenter kiosks as of December 31, 2021, requiring significant expansion.

What Could Drive MDVL Stock Higher?

• Expansion of MedCenter kiosk installations across the U.S. and Canada into new medical clinics, retail stores, and employer sites.
• Further development and adoption of the SpotRx retail pharmacy platform, enhancing its service offerings and market reach.
• Potential for new strategic partnerships with healthcare providers, employers, or retail chains to accelerate market penetration.
• Introduction of enhanced features or new technological advancements within the MedCenter or SpotRx ecosystems to improve efficiency and patient experience.

What Are the Key Risks for MDVL?

• Financial-distress signal — its Altman Z-Score of -14.74 sits in the distress zone (elevated bankruptcy risk).
• Significant negative profit margin of -110.5% and low gross margin of 6.0%, indicating substantial operational challenges and a path to profitability yet to be achieved.
• Intense competition from established retail pharmacy chains, mail-order pharmacies, and emerging digital health solutions.
• Regulatory hurdles and compliance costs associated with operating pharmacy services and deploying new technology across different jurisdictions in the U.S. and Canada.
• High capital requirements for expanding the MedCenter kiosk network, ongoing research and development, and scaling the SpotRx platform.
• Challenges in securing widespread adoption of self-service pharmacy solutions among patients and healthcare providers.

What Are the Growth Opportunities for MDVL?

• Expansion of MedCenter Kiosk Network: MedAvail's primary growth driver lies in scaling its MedCenter kiosk installations. As of December 31, 2021, the company operated 81 kiosks, indicating a nascent but established network. Future growth is anticipated through strategic deployment in high-traffic medical clinics, diverse retail store locations, and employer sites seeking convenient on-site healthcare solutions. This expansion capitalizes on the increasing demand for immediate prescription access and reduced wait times, particularly in areas where traditional pharmacy access may be limited or inconvenient. The ability to provide real-time pharmacist supervision via audio-visual connection further enhances the appeal and regulatory compliance of these self-service units, potentially opening doors to broader market adoption across the U.S. and Canada.
• Growth of SpotRx Retail Pharmacy Platform: The SpotRx platform represents MedAvail's direct retail pharmacy arm, complementing its technology segment. Expanding the reach and service offerings of SpotRx is a significant growth opportunity. This involves increasing patient enrollment, enhancing the mobile application experience, and potentially integrating with other healthcare ecosystems to streamline prescription management and delivery. By strengthening its retail pharmacy services, MedAvail can capture a larger share of the prescription market, leveraging its technology infrastructure for efficient fulfillment and patient engagement. The platform's growth can be driven by marketing efforts, partnerships with healthcare providers, and demonstrating superior patient convenience and service quality compared to traditional models.
• Increased Adoption in Underserved and Remote Areas: MedAvail's self-service pharmacy model is particularly well-suited for addressing healthcare deserts and improving prescription access in underserved or remote communities. The MedCenter kiosks, with their ability to provide on-site dispensing and remote pharmacist supervision, can bridge geographical gaps where establishing a full-service traditional pharmacy might be economically unfeasible. This growth opportunity involves strategic partnerships with local governments, community health centers, and rural healthcare providers to deploy kiosks in locations that currently lack adequate pharmacy services. By improving access, MedAvail can tap into a significant market segment while fulfilling a critical public health need, potentially attracting government incentives or grants.
• Technology Enhancements and New Features: Continuous innovation in its pharmacy technology solutions presents a substantial growth opportunity. This includes developing advanced features for the MedCenter kiosks, such as expanded medication capacity, enhanced security protocols, or integration with electronic health records (EHR) systems for seamless prescription management. For the SpotRx mobile application, new functionalities could include medication adherence tools, personalized health insights, or telemedicine integration. Investing in research and development to stay ahead of technological trends and competitive offerings can solidify MedAvail's market position and attract new users and partners. These enhancements can improve operational efficiency, patient experience, and expand the range of services offered.
• Strategic Partnerships and Collaborations: Forming strategic alliances with large healthcare systems, pharmacy benefit managers (PBMs), insurance providers, or major retail chains could significantly accelerate MedAvail's market penetration. Collaborations could involve deploying MedCenter kiosks within partner networks, integrating SpotRx services into existing healthcare platforms, or co-developing new solutions. Such partnerships can provide access to broader patient populations, leverage established distribution channels, and offer economies of scale. For instance, a partnership with a large employer could lead to widespread deployment of kiosks across their facilities, providing convenient pharmacy access to thousands of employees and their families, thereby expanding MedAvail's footprint rapidly and cost-effectively.

What Opportunities Does MDVL Have?

• Expansion of the MedCenter kiosk network into new geographic regions and diverse facility types.
• Growth in demand for convenient, decentralized healthcare and pharmacy services.
• Potential for strategic partnerships with large healthcare providers, employers, or retail chains.
• Further technological enhancements and feature additions to MedCenter and SpotRx platforms.

What Threats Does MDVL Face?

• Intense competition from established large pharmacy chains and emerging digital health platforms.
• Potential regulatory changes and compliance costs in the pharmaceutical and healthcare sectors.
• High capital requirements for continued research, development, and expansion of kiosk infrastructure.
• Challenges in consumer adoption and overcoming traditional pharmacy habits.

What Are MDVL's Competitive Advantages?

• Proprietary MedCenter kiosk technology for self-service prescription dispensing.
• Integrated audio-visual connection enabling real-time pharmacist supervision for compliance and safety.
• Dual business model encompassing both pharmacy technology development and direct retail pharmacy services (SpotRx).
• Focus on convenience and accessibility, differentiating from traditional pharmacy models.

What Does MDVL Do?

MedAvail Holdings, Inc. operates as a technology-enabled retail pharmacy technology and services company, headquartered in Mississauga, Canada. The company is dedicated to developing and commercializing innovative self-service pharmacy, mobile application, kiosk, and drive-thru solutions across the United States and Canada. Its operational framework is bifurcated into two distinct segments: Retail Pharmacy Services and Pharmacy Technology. The genesis of MedAvail's approach lies in addressing the evolving demands for accessible and convenient prescription dispensing. A cornerstone of MedAvail's offerings is the MedCenter, a proprietary self-service pharmacy kiosk. This technology facilitates on-site prescription dispensing in a diverse array of locations, including medical clinics, conventional retail store environments, employer sites (both those with and without integrated onsite clinics), and any other setting where immediate, on-site prescription access is desired. A critical feature of the MedCenter is its integrated audio-visual connection, which links patients directly to a live, licensed pharmacist. This real-time supervision ensures that prescription drug dispensing occurs under professional guidance, maintaining safety and compliance standards while enhancing patient convenience. Beyond its technology solutions, MedAvail also owns and operates SpotRx, a comprehensive retail pharmacy platform. SpotRx complements the MedCenter kiosks by providing a broader retail pharmacy service, likely encompassing prescription fulfillment, patient counseling, and other related services, further solidifying MedAvail's presence in the direct-to-patient pharmacy market. As of December 31, 2021, the company had deployed 81 MedCenter kiosks, indicating a foundational network for its technology-driven pharmacy model. The company's strategy focuses on leveraging technology to streamline the pharmacy experience, making prescription access more efficient and patient-centric, while adhering to necessary regulatory oversight through its live pharmacist supervision model. This dual approach, combining innovative technology with direct retail pharmacy operations, positions MedAvail to potentially disrupt traditional pharmacy models by offering a hybrid solution that prioritizes accessibility and supervised self-service.

What Products and Services Does MDVL Offer?

• Develops and commercializes self-service pharmacy technology solutions.
• Offers mobile application-based pharmacy services.
• Provides kiosk-based prescription dispensing through its MedCenter units.
• Develops drive-thru pharmacy solutions.
• Enables on-site pharmacy services in medical clinics, retail stores, and employer sites.
• Establishes audio-visual connections to live pharmacists for real-time prescription supervision.
• Owns and operates SpotRx, a retail pharmacy platform.
• Operates its solutions and services across the United States and Canada.

How Does MDVL Make Money?

• Generates revenue from its Retail Pharmacy Services segment, primarily through the SpotRx platform.
• Derives revenue from its Pharmacy Technology segment, including MedCenter kiosk sales/leases and related services.
• Facilitates prescription drug dispensing directly to patients via self-service kiosks and its retail platform.
• Provides real-time pharmacist supervision services through integrated audio-visual technology.

What Industry Does MDVL Operate In?

MedAvail Holdings, Inc. operates within the dynamic Medical - Pharmaceuticals industry, specifically targeting the retail pharmacy and healthcare technology sub-sectors. The broader industry is experiencing significant transformation, driven by increasing consumer demand for convenience, the integration of digital health solutions, and a focus on decentralized care models. MedAvail positions itself at the intersection of these trends by offering self-service pharmacy solutions that aim to enhance accessibility and efficiency in prescription dispensing. The competitive landscape includes traditional brick-and-mortar pharmacies, large pharmacy chains, mail-order pharmacies, and emerging telehealth platforms. MedAvail differentiates itself through its MedCenter kiosks, which provide on-site, immediate prescription access coupled with real-time audio-visual pharmacist supervision, a hybrid model that seeks to combine the speed of automation with the safety of professional oversight. This approach allows the company to target specific niches such as medical clinics and employer sites where on-demand pharmacy services can add significant value.

Who Are MDVL's Key Customers?

• Medical clinics seeking on-site pharmacy solutions.
• Retail store locations desiring in-store prescription dispensing.
• Employer sites (with and without onsite clinics) aiming to provide convenient employee pharmacy access.
• Patients in the United States and Canada seeking accessible and supervised prescription services.
• Other locations where on-site prescription dispensing is desired.

Net buyingInsider Activity

The most recent 11 insider filings for MedAvail Holdings, Inc. break down as 2 sales and 9 purchases. On net that is roughly 47.6M shares acquired (about $19.7M) — insiders putting money in tends to read as conviction.

F-Score 4/9Financial Health

MedAvail Holdings, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -14.74 places it in the distress zone, a signal of elevated financial risk.

MedAvail Holdings, Inc. (MDVL) Valuation Context

Valued at $2.91M, MDVL is classified as a micro-cap stock. Relative to its peer group, MDVL's quantitative score of 49/100 is below the peer average of 60/100.

MDVL Financials

MDVL Latest News

No recent news available for MDVL.

MDVL Analyst Consensus

MDVL MoonshotScore

What Investors Ask About MedAvail Holdings, Inc. (MDVL) — Healthcare

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources